Download FREE Report Sample
Download Free sampleA cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.
Piroxicam Market contains market size and forecasts of Piroxicam in Global, including the following market information:
Global Piroxicam Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Piroxicam market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
by Dosage Form Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Piroxicam include Pfizer, Teva, Mylan, Nostrum, DCPC, FANGMING, JINGHUA, JUMPCAN and Technilab Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Piroxicam companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Piroxicam Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Piroxicam Market Segment Percentages, by Type, 2021 (%)
by Dosage Form
Suppositories
Injection
Capsule
Patch
Other
by Route
Oral
Rectal
Global Piroxicam Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Piroxicam Market Segment Percentages, by Application, 2021 (%)
Tendonitis
Systemic Traumatic Pain
Musculoskeletal Pain
Contraception
Rheumatoid Arthritis
Chronic Infectious Arthritis
Osteoarthritis
Other
Global Piroxicam Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Piroxicam Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Piroxicam revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Piroxicam revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Teva
Mylan
Nostrum
DCPC
FANGMING
JINGHUA
JUMPCAN
Technilab Pharma
Apotex Corporation
Keltman Pharmaceuticals
Genpharm
Bayer
PLX Pharma
Chiesi
SK Chemicals
Bioglan Laboratories
APR
CJ HealthCare
SkyePharma
Changzhou Siyao Pharmaceutical
Shanxi Yunpeng Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
